TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 3241891

Group type: EXPERIMENTAL
Intervention: AO screws
Number of subjects: 110

Group type: COMPARATOR
Intervention: Hook-pins
Number of subjects: 110
Study: 31957558

Group type: EXPERIMENTAL
Intervention: 600mg DHA/day
Number of subjects: 167

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 167
Study: 29543499

Group type: EXPERIMENTAL
Intervention: Contingency Management (CM)
Number of subjects: 37

Group type: EXPERIMENTAL
Intervention: Alcohol Use Feedback (FB)
Number of subjects: 37

Group type: COMPARATOR
Intervention: TAM device only (CTL)
Number of subjects: 37

Group type: EXPERIMENTAL
Intervention: TAM device
Number of subjects: 37
Study: 28224397

Group type: EXPERIMENTAL
Intervention: Pathogen-specific food safety instruction
Number of subjects: 550

Group type: COMPARATOR
Intervention: Basic food safety instruction (active control)
Number of subjects: 550
Study: 26378978

Group type: EXPERIMENTAL
Intervention: Empagliflozin (10 mg or 25 mg once daily)
Number of subjects: 7020

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 7020

Group type: EXPERIMENTAL
Intervention: Empagliflozin
Number of subjects: 7020
Study: 24334183

Group type: EXPERIMENTAL
Intervention: Pioglitazone (PIO; 30 mg/d)
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Exercise training (EXS; 90-120 min/d, 3 d/wk)
Number of subjects: 24

Group type: COMPARATOR
Intervention: Control group not specified
Number of subjects: 24
Study: 20510464

Group type: EXPERIMENTAL
Intervention: High-frequency (10 Hz) rTMS over the left dorsolateral prefrontal cortex
Number of subjects: 14

Group type: EXPERIMENTAL
Intervention: One session of rTMS
Number of subjects: 14
Study: 18510207

Group type: EXPERIMENTAL
Intervention: Nutrition intervention package (weekly 30-minute sessions for 7 weeks)
Number of subjects: 1275

Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 1275

Group type: COMPARATOR
Intervention: Comparison group (RMP training only)
Number of subjects: 1275
Study: 16630304

Group type: EXPERIMENTAL
Intervention: Clinpro Cario L-Pop (CCLP) test
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Antimicrobial toothpaste and mouthwash
Number of subjects: 30

Group type: COMPARATOR
Intervention: Capillary ion electrophoresis (CIA) for lactic acid measurement
Number of subjects: 30
Study: 12057884

Group type: EXPERIMENTAL
Intervention: Doxycycline (200 mg/day)
Number of subjects: 491

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 491
Study: 10476937

Group type: EXPERIMENTAL
Intervention: 20 IU of nHuIFN-alpha
Number of subjects: 368

Group type: EXPERIMENTAL
Intervention: 200 IU of nHuIFN-alpha
Number of subjects: 368

Group type: COMPARATOR
Intervention: 400 IU of nHuIFN-alpha
Number of subjects: 368

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 368
Study: 8726601

Group type: EXPERIMENTAL
Intervention: Fasting conditions
Number of subjects: 12

Group type: COMPARATOR
Intervention: Postprandial conditions
Number of subjects: 12
Study: 1765528

Group type: EXPERIMENTAL
Intervention: Parent education package (PEP)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 0
Study: 7076369

Group type: EXPERIMENTAL
Intervention: Medium dose of methadone
Number of subjects: 76

Group type: EXPERIMENTAL
Intervention: Low dose of methadone
Number of subjects: 76

Group type: EXPERIMENTAL
Intervention: High dose of methadone
Number of subjects: 76

Group type: COMPARATOR
Intervention: Naloxone administration
Number of subjects: 76
Study: 29672533

Group type: EXPERIMENTAL
Intervention: Cup-type respirator with direct laryngoscope
Number of subjects: 26

Group type: COMPARATOR
Intervention: GlideScope with cup-type respirator
Number of subjects: 26

Group type: COMPARATOR
Intervention: i-gel with cup-type respirator
Number of subjects: 26

Group type: COMPARATOR
Intervention: Fold-type respirator with any airway device
Number of subjects: 26
Study: 27484821

Group type: EXPERIMENTAL
Intervention: Training to generate a Continuity of Care Document (CCD) using the Blue Button feature of the VA patient portal
Number of subjects: 52

Group type: COMPARATOR
Intervention: Attention control: Training to look up health information on the Internet
Number of subjects: 52

Group type: EXPERIMENTAL
Intervention: Sharing CCD prior to non-VA providers ordering laboratory tests
Number of subjects: 52

Group type: EXPERIMENTAL
Intervention: Comparison of medical records between VA and non-VA providers
Number of subjects: 52
Study: 25664444

Group type: EXPERIMENTAL
Intervention: Lung-RADS
Number of subjects: 26722

Group type: COMPARATOR
Intervention: NLST
Number of subjects: 26722
Study: 24136928

Group type: EXPERIMENTAL
Intervention: PHEN/TPM ER 7.5/46 mg
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: PHEN/TPM ER 15/92 mg
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Phentermine 7.5 mg
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Phentermine 15 mg
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Topiramate ER 46 mg
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Topiramate ER 92 mg
Number of subjects: 0
Study: 21094802

Group type: EXPERIMENTAL
Intervention: belatacept
Number of subjects: 27

Group type: COMPARATOR
Intervention: cyclosporine
Number of subjects: 27
Study: 18291550

Group type: EXPERIMENTAL
Intervention: Carbapenems
Number of subjects: 1591

Group type: EXPERIMENTAL
Intervention: Linezolid
Number of subjects: 1591

Group type: COMPARATOR
Intervention: Other antibiotics
Number of subjects: 1591

Group type: EXPERIMENTAL
Intervention: Patients with osteomyelitis
Number of subjects: 1591
Study: 16845957

Group type: EXPERIMENTAL
Intervention: Upper jaw extraction (two first or second premolars)
Number of subjects: 52

Group type: COMPARATOR
Intervention: Upper and lower jaw extraction (four premolars)
Number of subjects: 52
Study: 14669189

Group type: EXPERIMENTAL
Intervention: Task-specific (TS) motor learning format
Number of subjects: 18

Group type: COMPARATOR
Intervention: Task-nonspecific (TNS) motor learning format
Number of subjects: 18
Study: 10607766

Group type: EXPERIMENTAL
Intervention: PGE(1) 10 ng/kg bodyweight/min
Number of subjects: 130

Group type: EXPERIMENTAL
Intervention: PGE(1) 20 ng/kg bodyweight/min
Number of subjects: 130

Group type: EXPERIMENTAL
Intervention: PGE(1) 40 ng/kg bodyweight/min
Number of subjects: 130

Group type: COMPARATOR
Intervention: Placebo (physiologic sodium chloride solution)
Number of subjects: 130
Study: 9193328

Group type: EXPERIMENTAL
Intervention: Epirubicin 120 mg/m2 and Cyclophosphamide 700 mg/m2 every 21 days
Number of subjects: 49

Group type: EXPERIMENTAL
Intervention: Epirubicin 75 mg/m2 and Cyclophosphamide 500 mg/m2 every 10 days
Number of subjects: 49

Group type: EXPERIMENTAL
Intervention: Epirubicin 75 mg/m2 and Cyclophosphamide 500 mg/m2 every 8 days
Number of subjects: 49
Study: 8130662

Group type: EXPERIMENTAL
Intervention: Ohmeda Biox 3700 pulse oximeter
Number of subjects: 0

Group type: COMPARATOR
Intervention: Baxter Asat 100 pulse oximeter
Number of subjects: 0
Study: 3702764

Group type: EXPERIMENTAL
Intervention: Organon OD 14 (Tibolone)
Number of subjects: 15

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 15
Study: 30664500

Group type: EXPERIMENTAL
Intervention: Active upper extremity neural mobilization
Number of subjects: 44

Group type: EXPERIMENTAL
Intervention: Passive upper extremity neural mobilization
Number of subjects: 44
Study: 28278459

Group type: EXPERIMENTAL
Intervention: Fast Randomized Singular Value Thresholding (FRSVT)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Nuclear Norm Minimization (NNM)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Weighted Nuclear Norm Minimization (WNNM)
Number of subjects: 0
Study: 27265742

Group type: EXPERIMENTAL
Intervention: Bavituximab 3 mg/kg
Number of subjects: 121

Group type: COMPARATOR
Intervention: Placebo/Bavituximab 1 mg/kg
Number of subjects: 121
Study: 25176263

Group type: EXPERIMENTAL
Intervention: Cerebrolysin
Number of subjects: 300

Group type: COMPARATOR
Intervention: Control group (no cerebrolysin)
Number of subjects: 300
Study: 22355055

Group type: EXPERIMENTAL
Intervention: Treatment for high-grade gliomas
Number of subjects: 54
Study: 19768515

Group type: EXPERIMENTAL
Intervention: Delta ceramic-on-ceramic (COC)
Number of subjects: 263

Group type: COMPARATOR
Intervention: Delta ceramic head-crosslinked polyethylene (COP)
Number of subjects: 263
Study: 19142489

Group type: EXPERIMENTAL
Intervention: Raloxifene 60 mg for 22 days
Number of subjects: 33

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 33
Study: 15671123

Group type: EXPERIMENTAL
Intervention: Tyrosine and phenylalanine deficient mixture (TP‐)
Number of subjects: 12

Group type: COMPARATOR
Intervention: Balanced amino-acid drink (Bal)
Number of subjects: 12
Study: 14989050

Group type: EXPERIMENTAL
Intervention: Ursodeoxycholic acid (UDCA)
Number of subjects: 0
Study: 10785301

Group type: EXPERIMENTAL
Intervention: Fuji II LC
Number of subjects: 26

Group type: EXPERIMENTAL
Intervention: Vitremer
Number of subjects: 26

Group type: EXPERIMENTAL
Intervention: Photac-Fil Quick
Number of subjects: 26

Group type: EXPERIMENTAL
Intervention: Pulpal pressure of 15cm H(2)O
Number of subjects: 26

Group type: COMPARATOR
Intervention: No pulpal pressure
Number of subjects: 26
Study: 8842609

Group type: EXPERIMENTAL
Intervention: Glipizide gastrointestinal therapeutic system (GITS)
Number of subjects: 13

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 13
Study: 1476025

Group type: EXPERIMENTAL
Intervention: Injections of allergen-antibody complexes made of D. pteronyssinus allergens and specific autologous antibodies.
Number of subjects: 23

Group type: COMPARATOR
Intervention: Placebo (control group).
Number of subjects: 23
Study: 3157008

Group type: EXPERIMENTAL
Intervention: Norfloxacin 400 mg
Number of subjects: 40

Group type: COMPARATOR
Intervention: Trimethoprim-sulfamethoxazole 160 mg and 800 mg respectively, twice daily for 10 days
Number of subjects: 40
Study: 31621640

Group type: EXPERIMENTAL
Intervention: I‐ACE tool (experimental arm)
Number of subjects: 50

Group type: COMPARATOR
Intervention: SLA methods (comparison arm)
Number of subjects: 50
Study: 29987678

Group type: EXPERIMENTAL
Intervention: Roux-en-Y gastric bypass (RYGB)
Number of subjects: 61

Group type: EXPERIMENTAL
Intervention: Sleeve gastrectomy (SG)
Number of subjects: 61

Group type: EXPERIMENTAL
Intervention: Changes in prandial FGF19
Number of subjects: 61
Study: 26971035

Group type: EXPERIMENTAL
Intervention: rtPA group
Number of subjects: 18

Group type: COMPARATOR
Intervention: non-rtPA group
Number of subjects: 18
Study: 24676651

Group type: EXPERIMENTAL
Intervention: Intravenous metamizole 1.5 g every 8 h during the first 24 postoperative hours
Number of subjects: 110

Group type: COMPARATOR
Intervention: Intravenous paracetamol 1 g every 8 h during the first 24 postoperative hours
Number of subjects: 110
Study: 19900742

Group type: EXPERIMENTAL
Intervention: Supportive patient-practitioner relationship
Number of subjects: 289

Group type: COMPARATOR
Intervention: Experiential interview (additional opportunity to discuss illness)
Number of subjects: 289
Study: 15599778

Group type: EXPERIMENTAL
Intervention: Ceftriaxone and amikacin (CA regimen)
Number of subjects: 224

Group type: EXPERIMENTAL
Intervention: Piperacillin-tazobactam and amikacin (PTA regimen)
Number of subjects: 224
Study: 12039127

Group type: EXPERIMENTAL
Intervention: Adenosine-receptor blocker 8-sulfophenyltheophylline
Number of subjects: 16

Group type: COMPARATOR
Intervention: Normal pregnancy
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: Preeclampsia
Number of subjects: 16
Study: 9692161

Group type: EXPERIMENTAL
Intervention: Chloroquine plus chlorpheniramine (CQ/CP)
Number of subjects: 100

Group type: COMPARATOR
Intervention: Pyrimethamine/sulfadoxine (PS)
Number of subjects: 100
Study: 7911143

Group type: EXPERIMENTAL
Intervention: Lumen used for repeat infusions and injections
Number of subjects: 28

Group type: EXPERIMENTAL
Intervention: Lumen permanently connected to slow infusion of 0.9% NaCl
Number of subjects: 28

Group type: COMPARATOR
Intervention: Catheter-tip cultures
Number of subjects: 28
Study: 3293479

Group type: EXPERIMENTAL
Intervention: midazolam-fentanyl-N2O/O2 anesthesia
Number of subjects: 16

Group type: COMPARATOR
Intervention: halothane-N2O/O2 anesthesia
Number of subjects: 16
Study: 11314852

Group type: EXPERIMENTAL
Intervention: Women describing throat, neck or jaw pain
Number of subjects: 200

Group type: EXPERIMENTAL
Intervention: Women giving accounts of breathlessness and other symptoms
Number of subjects: 200

Group type: EXPERIMENTAL
Intervention: Gender differences in language use
Number of subjects: 200
Study: 31193184

Group type: EXPERIMENTAL
Intervention: B-CBCT-Office
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: B-CBCT-Home
Number of subjects: 0

Group type: COMPARATOR
Intervention: PTSD Family Education
Number of subjects: 0
Study: 28857770

Group type: EXPERIMENTAL
Intervention: Group rehabilitation exercises supervised by a physical therapist
Number of subjects: 74

Group type: COMPARATOR
Intervention: Home exercises
Number of subjects: 74
Study: 26853137

Group type: EXPERIMENTAL
Intervention: Continue antihypertensive drugs
Number of subjects: 246

Group type: COMPARATOR
Intervention: Stop antihypertensive drugs
Number of subjects: 246
Study: 25046622

Group type: EXPERIMENTAL
Intervention: Lipo-botulinum toxin instillation
Number of subjects: 62

Group type: COMPARATOR
Intervention: Placebo (normal saline)
Number of subjects: 62
Study: 22113647

Group type: EXPERIMENTAL
Intervention: Increased daily water intake by 1.5 l
Number of subjects: 102

Group type: COMPARATOR
Intervention: Control group (no additional water intake)
Number of subjects: 102
Study: 20413122

Group type: EXPERIMENTAL
Intervention: Po-husk (14 g/d)
Number of subjects: 254

Group type: COMPARATOR
Intervention: Simvastatin (20 mg/d) added to Po-husk or placebo
Number of subjects: 254
Study: 17666596

Group type: COMPARATOR
Intervention: Operative laparoscopy
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Laparoscopically guided minilaparotomy
Number of subjects: 60
Study: 15745138

Group type: EXPERIMENTAL
Intervention: Reduction of Cndi in steps of 0.2 mS/cm
Number of subjects: 28
Study: 11821217

Group type: EXPERIMENTAL
Intervention: Naproxen 0.1%
Number of subjects: 101

Group type: EXPERIMENTAL
Intervention: Naproxen 0.2%
Number of subjects: 101

Group type: COMPARATOR
Intervention: Diclofenac 0.1%
Number of subjects: 101
Study: 9701205

Group type: EXPERIMENTAL
Intervention: Retroperitoneal partial 'no-closure'
Number of subjects: 61

Group type: COMPARATOR
Intervention: Closure
Number of subjects: 61
Study: 8134281

Group type: EXPERIMENTAL
Intervention: 201Tl
Number of subjects: 37

Group type: EXPERIMENTAL
Intervention: 99mTc‐MIBI
Number of subjects: 37

Group type: EXPERIMENTAL
Intervention: SPECT
Number of subjects: 37

Group type: COMPARATOR
Intervention: Planar scintigraphy
Number of subjects: 37
Study: 2674063

Group type: EXPERIMENTAL
Intervention: Cefazolin and Ornidazole (CO)
Number of subjects: 100

Group type: COMPARATOR
Intervention: Cefazolin and Placebo (CP)
Number of subjects: 100
Study: 1091282

Group type: EXPERIMENTAL
Intervention: Intermediate coronary care (nursed by CCU staff, resuscitation equipment available, efficient emergency call system)
Number of subjects: 1000

Group type: EXPERIMENTAL
Intervention: Intermediate coronary care
Number of subjects: 1000

Group type: COMPARATOR
Intervention: Control group (discharged from CCU to general medical ward)
Number of subjects: 1000

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 1000
Study: 31420724

Group type: EXPERIMENTAL
Intervention: Intermittent Pringle Maneuver (IPM)
Number of subjects: 176

Group type: COMPARATOR
Intervention: No-Pringle Maneuver (NPM)
Number of subjects: 176
Study: 29349980

Group type: EXPERIMENTAL
Intervention: Arthroscopic debridement with continuous irrigation using sensitive antibiotics for 2-3 weeks
Number of subjects: 11

Group type: COMPARATOR
Intervention: Open surgical debridement
Number of subjects: 11
Study: 26745049

Group type: EXPERIMENTAL
Intervention: Back massage for 15 minutes per day for a week
Number of subjects: 44
Study: 24460280

Group type: EXPERIMENTAL
Intervention: Health Partner Program (8 weeks of training in health management, leadership, and coaching)
Number of subjects: 70

Group type: EXPERIMENTAL
Intervention: Health Partner Program
Number of subjects: 70

Group type: COMPARATOR
Intervention: Waiting-list control group
Number of subjects: 70
Study: 21488521

Group type: EXPERIMENTAL
Intervention: Psychoeducational training program in affect regulation (n=8)
Number of subjects: 19

Group type: COMPARATOR
Intervention: Inpatient treatment as usual (Control group, n=11)
Number of subjects: 19
Study: 19784508

Group type: EXPERIMENTAL
Intervention: 0.5% ropivacaine
Number of subjects: 101

Group type: EXPERIMENTAL
Intervention: 0.5% bupivacaine
Number of subjects: 101

Group type: COMPARATOR
Intervention: Parasacral approach
Number of subjects: 101

Group type: EXPERIMENTAL
Intervention: Probit regression for 95% of patients in parasacral approach
Number of subjects: 101

Group type: EXPERIMENTAL
Intervention: Probit regression for 95% of patients in infragluteal-parabiceps approach
Number of subjects: 101

Group type: EXPERIMENTAL
Intervention: Parasacral SNB
Number of subjects: 101

Group type: EXPERIMENTAL
Intervention: Infragluteal-parabiceps approach
Number of subjects: 101
Study: 16539738

Group type: EXPERIMENTAL
Intervention: Trypan blue (0.06%) used for posterior capsulorhexis with optic capture
Number of subjects: 35

Group type: COMPARATOR
Intervention: No dye used for posterior capsulorhexis
Number of subjects: 35
Study: 14982865

Group type: EXPERIMENTAL
Intervention: Pharmacare restricted reimbursement for nebulised bronchodilators, steroids, and cromoglycate with individual patient exemptions.
Number of subjects: 449

Group type: COMPARATOR
Intervention: Control group offered a six month exemption from the reimbursement restriction.
Number of subjects: 449
Study: 10962052

Group type: EXPERIMENTAL
Intervention: Metronidazole (3x400 mg orally per day), mesalazine (3x1 g orally per day), and betamethasone enema (once a day during 4 weeks)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Mesalazine and betamethasone enema without metronidazole
Number of subjects: 60
Study: 9276108

Group type: EXPERIMENTAL
Intervention: Chronic stimulation of the left vagus nerve (VNS) for 28 months
Number of subjects: 6

Group type: EXPERIMENTAL
Intervention: High frequency stimulation of the left vagus nerve (VNS)
Number of subjects: 6
Study: 8503246

Group type: EXPERIMENTAL
Intervention: 60, 125 or 250 micrograms/m2/day of rhGM‐CSF
Number of subjects: 46
Study: 3662563

Group type: EXPERIMENTAL
Intervention: Trade name glucocorticoids (triamcinolone acetonide, fluocinolone acetonide, betamethasone valerate)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Generic formulations of triamcinolone acetonide, fluocinolone acetonide, and betamethasone valerate
Number of subjects: 0
Study: 31424375

Group type: EXPERIMENTAL
Intervention: Working Memory (WM) training (n-back training) for 15 sessions over five weeks
Number of subjects: 21

Group type: COMPARATOR
Intervention: Passive control group
Number of subjects: 21

Group type: EXPERIMENTAL
Intervention: Working Memory (WM) training
Number of subjects: 21
Study: 28778685

Group type: EXPERIMENTAL
Intervention: Ondansetron
Number of subjects: 175

Group type: EXPERIMENTAL
Intervention: Bromopride
Number of subjects: 175

Group type: EXPERIMENTAL
Intervention: Metoclopramide
Number of subjects: 175
Study: 27802924

Group type: EXPERIMENTAL
Intervention: DBPTB allografts
Number of subjects: 101

Group type: COMPARATOR
Intervention: 4SHS grafts
Number of subjects: 101
Study: 24917632

Group type: EXPERIMENTAL
Intervention: Osteopathic manipulative treatment (OMT)
Number of subjects: 33

Group type: COMPARATOR
Intervention: Sham therapy
Number of subjects: 33
Study: 22917825

Group type: COMPARATOR
Intervention: Percutaneous Coronary Intervention (PCI) with sirolimus‐eluting stent
Number of subjects: 301

Group type: EXPERIMENTAL
Intervention: Coronary Artery Bypass Grafting (CABG)
Number of subjects: 301
Study: 20554511

Group type: EXPERIMENTAL
Intervention: Verum acupuncture (VA)
Number of subjects: 17

Group type: COMPARATOR
Intervention: Placebo acupuncture (PA)
Number of subjects: 17
Study: 18396709

Group type: EXPERIMENTAL
Intervention: Wound-healing hydrogel (group A)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Normal saline (group B)
Number of subjects: 60
Study: 15715531

Group type: EXPERIMENTAL
Intervention: 20 mg ferrous iron
Number of subjects: 427

Group type: EXPERIMENTAL
Intervention: 40 mg ferrous iron
Number of subjects: 427

Group type: EXPERIMENTAL
Intervention: 60 mg ferrous iron
Number of subjects: 427

Group type: EXPERIMENTAL
Intervention: 80 mg ferrous iron
Number of subjects: 427
Study: 12646336

Group type: EXPERIMENTAL
Intervention: Rosuvastatin 5 mg
Number of subjects: 1951

Group type: EXPERIMENTAL
Intervention: Rosuvastatin 10 mg
Number of subjects: 1951
Study: 10357371

Group type: EXPERIMENTAL
Intervention: SQV‐SGC 1200 mg three times per day
Number of subjects: 70

Group type: COMPARATOR
Intervention: Indinavir 800 mg three times per day
Number of subjects: 70
Study: 8706276

Group type: EXPERIMENTAL
Intervention: Acupuncture treatment
Number of subjects: 0
Study: 1709781

Group type: EXPERIMENTAL
Intervention: Intraumbilical vein administration of 10 IU of oxytocin in 20 ml of saline solution
Number of subjects: 220

Group type: COMPARATOR
Intervention: Placebo injection
Number of subjects: 220
Study: 6165817

Group type: EXPERIMENTAL
Intervention: Intrasulcular brushing technique for 30 seconds daily for 49 days
Number of subjects: 24

Group type: COMPARATOR
Intervention: Extrasulcular brushing technique for 30 seconds daily for 49 days
Number of subjects: 24
Study: 30739006

Group type: EXPERIMENTAL
Intervention: Mindfulness-based stress reduction (MBSR) training
Number of subjects: 0

Group type: COMPARATOR
Intervention: Active control groups
Number of subjects: 0
Study: 26920858

Group type: EXPERIMENTAL
Intervention: Rate of divergence analysis
Number of subjects: 150

Group type: COMPARATOR
Intervention: Traditional perturbation and nonlinear methods
Number of subjects: 150
Study: 25257236

Group type: EXPERIMENTAL
Intervention: Cluster-hole acetabular component
Number of subjects: 100

Group type: COMPARATOR
Intervention: Solid-backed acetabular component
Number of subjects: 100
Study: 23802121

Group type: EXPERIMENTAL
Intervention: Oxytocin
Number of subjects: 26

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 26
Study: 22140499

Group type: EXPERIMENTAL
Intervention: Prebiotic formula group (regular formula containing a mixture of neutral oligosaccharides and pectin-derived acidic oligosaccharides)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control formula group (regular formula without oligosaccharides)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Both prebiotic and control groups
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Breastfeeding group
Number of subjects: 0
Study: 19622553

Group type: EXPERIMENTAL
Intervention: artemether-lumefantrine
Number of subjects: 175

Group type: COMPARATOR
Intervention: quinine
Number of subjects: 175

Group type: EXPERIMENTAL
Intervention: adherence levels of 80% or more
Number of subjects: 175

Group type: EXPERIMENTAL
Intervention: adverse events
Number of subjects: 175